Potassium Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials

Detalhes bibliográficos
Autor(a) principal: Filippini, T
Data de Publicação: 2020
Outros Autores: Naska, A, Kasdagli, MI, Torres, D, Lopes, C, Carvalho, C, Moreira, P, Malavolti, M, Orsini, N, Whelton, PK, Vinceti, M
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://hdl.handle.net/10216/143217
Resumo: Background. Epidemiologic studies, including trials, suggest an association between potassium intake and blood pressure (BP). However, the strength and shape of this relationship is uncertain. Methods and Results. We performed a meta‐analysis to explore the dose‐response relationship between potassium supplementation and BP in randomized‐controlled trials with a duration ≥4 weeks using the recently developed 1‐stage cubic spline regression model. This model allows use of trials with at least 2 exposure categories. We identified 32 eligible trials. Most were conducted in adults with hypertension using a crossover design and potassium supplementation doses that ranged from 30 to 140 mmol/d. We observed a U‐shaped relationship between 24‐hour active and control arm differences in potassium excretion and BP levels, with weakening of the BP reduction effect above differences of 30 mmol/d and a BP increase above differences ≈80 mmol/d. Achieved potassium excretion analysis also identified a U‐shaped relationship. The BP‐lowering effects of potassium supplementation were stronger in participants with hypertension and at higher levels of sodium intake. The BP increase with high potassium excretion was noted in participants with antihypertensive drug‐treated hypertension but not in their untreated counterparts. Conclusions. We identified a nonlinear relationship between potassium intake and both systolic and diastolic BP, although estimates for BP effects of high potassium intakes should be interpreted with caution because of limited availability of trials. Our findings indicate an adequate intake of potassium is desirable to achieve a lower BP level but suggest excessive potassium supplementation should be avoided, particularly in specific subgroups.
id RCAP_09470ca9bb7c9734b53f5436fd372d19
oai_identifier_str oai:repositorio-aberto.up.pt:10216/143217
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Potassium Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trialsblood pressuredietary supplementdose-response meta-analysispotassiumBackground. Epidemiologic studies, including trials, suggest an association between potassium intake and blood pressure (BP). However, the strength and shape of this relationship is uncertain. Methods and Results. We performed a meta‐analysis to explore the dose‐response relationship between potassium supplementation and BP in randomized‐controlled trials with a duration ≥4 weeks using the recently developed 1‐stage cubic spline regression model. This model allows use of trials with at least 2 exposure categories. We identified 32 eligible trials. Most were conducted in adults with hypertension using a crossover design and potassium supplementation doses that ranged from 30 to 140 mmol/d. We observed a U‐shaped relationship between 24‐hour active and control arm differences in potassium excretion and BP levels, with weakening of the BP reduction effect above differences of 30 mmol/d and a BP increase above differences ≈80 mmol/d. Achieved potassium excretion analysis also identified a U‐shaped relationship. The BP‐lowering effects of potassium supplementation were stronger in participants with hypertension and at higher levels of sodium intake. The BP increase with high potassium excretion was noted in participants with antihypertensive drug‐treated hypertension but not in their untreated counterparts. Conclusions. We identified a nonlinear relationship between potassium intake and both systolic and diastolic BP, although estimates for BP effects of high potassium intakes should be interpreted with caution because of limited availability of trials. Our findings indicate an adequate intake of potassium is desirable to achieve a lower BP level but suggest excessive potassium supplementation should be avoided, particularly in specific subgroups.Wiley20202020-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10216/143217eng2047-998010.1161/JAHA.119.015719Filippini, TNaska, AKasdagli, MITorres, DLopes, CCarvalho, CMoreira, PMalavolti, MOrsini, NWhelton, PKVinceti, Minfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-29T14:50:44Zoai:repositorio-aberto.up.pt:10216/143217Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T00:09:53.749815Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Potassium Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials
title Potassium Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials
spellingShingle Potassium Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials
Filippini, T
blood pressure
dietary supplement
dose-response meta-analysis
potassium
title_short Potassium Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials
title_full Potassium Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials
title_fullStr Potassium Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials
title_full_unstemmed Potassium Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials
title_sort Potassium Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials
author Filippini, T
author_facet Filippini, T
Naska, A
Kasdagli, MI
Torres, D
Lopes, C
Carvalho, C
Moreira, P
Malavolti, M
Orsini, N
Whelton, PK
Vinceti, M
author_role author
author2 Naska, A
Kasdagli, MI
Torres, D
Lopes, C
Carvalho, C
Moreira, P
Malavolti, M
Orsini, N
Whelton, PK
Vinceti, M
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Filippini, T
Naska, A
Kasdagli, MI
Torres, D
Lopes, C
Carvalho, C
Moreira, P
Malavolti, M
Orsini, N
Whelton, PK
Vinceti, M
dc.subject.por.fl_str_mv blood pressure
dietary supplement
dose-response meta-analysis
potassium
topic blood pressure
dietary supplement
dose-response meta-analysis
potassium
description Background. Epidemiologic studies, including trials, suggest an association between potassium intake and blood pressure (BP). However, the strength and shape of this relationship is uncertain. Methods and Results. We performed a meta‐analysis to explore the dose‐response relationship between potassium supplementation and BP in randomized‐controlled trials with a duration ≥4 weeks using the recently developed 1‐stage cubic spline regression model. This model allows use of trials with at least 2 exposure categories. We identified 32 eligible trials. Most were conducted in adults with hypertension using a crossover design and potassium supplementation doses that ranged from 30 to 140 mmol/d. We observed a U‐shaped relationship between 24‐hour active and control arm differences in potassium excretion and BP levels, with weakening of the BP reduction effect above differences of 30 mmol/d and a BP increase above differences ≈80 mmol/d. Achieved potassium excretion analysis also identified a U‐shaped relationship. The BP‐lowering effects of potassium supplementation were stronger in participants with hypertension and at higher levels of sodium intake. The BP increase with high potassium excretion was noted in participants with antihypertensive drug‐treated hypertension but not in their untreated counterparts. Conclusions. We identified a nonlinear relationship between potassium intake and both systolic and diastolic BP, although estimates for BP effects of high potassium intakes should be interpreted with caution because of limited availability of trials. Our findings indicate an adequate intake of potassium is desirable to achieve a lower BP level but suggest excessive potassium supplementation should be avoided, particularly in specific subgroups.
publishDate 2020
dc.date.none.fl_str_mv 2020
2020-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://hdl.handle.net/10216/143217
url https://hdl.handle.net/10216/143217
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 2047-9980
10.1161/JAHA.119.015719
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Wiley
publisher.none.fl_str_mv Wiley
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799136023835312128